The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032 ...
May 12, 2022 — Vivalink, a leading provider of digital healthcare solutions, announced availability of the world’s first ...
May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
May 11, 2022 — Women who experienced complications related to developing high blood pressure, or hypertension, during ...
May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a ...
May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
In April, the cardiology community converged face-to-face in Orlando for The American College of Cardiology’s (ACC22) ...
May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...
May 10, 2022 — MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 10, 2022 — After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) ...
May 10, 2022 — Faraday Pharmaceuticals, Inc., today announced the enrollment of the first patient in its Iocyte AMI-3 ...
May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...
May 9, 2022 — CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of ...
The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period ...
May 12, 2022
